Your browser doesn't support javascript.
loading
EphrinB2 repression through ZEB2 mediates tumour invasion and anti-angiogenic resistance.
Depner, C; Zum Buttel, H; Bögürcü, N; Cuesta, A M; Aburto, M R; Seidel, S; Finkelmeier, F; Foss, F; Hofmann, J; Kaulich, K; Barbus, S; Segarra, M; Reifenberger, G; Garvalov, B K; Acker, T; Acker-Palmer, A.
Afiliação
  • Depner C; Institute of Neuropathology, University of Giessen, Arndtstr. 16, D-35392 Giessen, Germany.
  • Zum Buttel H; Institute of Cell Biology and Neuroscience and Buchmann Institute for Molecular Life Sciences (BMLS), University of Frankfurt, Max-von-Laue-Str. 15, D-60438 Frankfurt am Main, Germany.
  • Bögürcü N; Institute of Neuropathology, University of Giessen, Arndtstr. 16, D-35392 Giessen, Germany.
  • Cuesta AM; Institute of Cell Biology and Neuroscience and Buchmann Institute for Molecular Life Sciences (BMLS), University of Frankfurt, Max-von-Laue-Str. 15, D-60438 Frankfurt am Main, Germany.
  • Aburto MR; Institute of Cell Biology and Neuroscience and Buchmann Institute for Molecular Life Sciences (BMLS), University of Frankfurt, Max-von-Laue-Str. 15, D-60438 Frankfurt am Main, Germany.
  • Seidel S; Focus Program Translational Neurosciences (FTN), University of Mainz, Langenbeckstr. 1, D-55131 Mainz, Germany.
  • Finkelmeier F; Institute of Neuropathology, University of Giessen, Arndtstr. 16, D-35392 Giessen, Germany.
  • Foss F; Institute of Neuropathology, University of Giessen, Arndtstr. 16, D-35392 Giessen, Germany.
  • Hofmann J; Institute of Cell Biology and Neuroscience and Buchmann Institute for Molecular Life Sciences (BMLS), University of Frankfurt, Max-von-Laue-Str. 15, D-60438 Frankfurt am Main, Germany.
  • Kaulich K; Focus Program Translational Neurosciences (FTN), University of Mainz, Langenbeckstr. 1, D-55131 Mainz, Germany.
  • Barbus S; Institute of Cell Biology and Neuroscience and Buchmann Institute for Molecular Life Sciences (BMLS), University of Frankfurt, Max-von-Laue-Str. 15, D-60438 Frankfurt am Main, Germany.
  • Segarra M; Department of Neuropathology, Heinrich Heine University of Düsseldorf, Düsseldorf and German Cancer Consortium (DKTK), Moorenstr. 5, 40225 partner site Essen/Düsseldorf, Germany.
  • Reifenberger G; Division of Molecular Genetics, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, D-69120 Heidelberg, Germany.
  • Garvalov BK; Institute of Cell Biology and Neuroscience and Buchmann Institute for Molecular Life Sciences (BMLS), University of Frankfurt, Max-von-Laue-Str. 15, D-60438 Frankfurt am Main, Germany.
  • Acker T; Department of Neuropathology, Heinrich Heine University of Düsseldorf, Düsseldorf and German Cancer Consortium (DKTK), Moorenstr. 5, 40225 partner site Essen/Düsseldorf, Germany.
  • Acker-Palmer A; Institute of Neuropathology, University of Giessen, Arndtstr. 16, D-35392 Giessen, Germany.
Nat Commun ; 7: 12329, 2016 07 29.
Article em En | MEDLINE | ID: mdl-27470974

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Resistencia a Medicamentos Antineoplásicos / Efrina-B2 / Homeobox 2 de Ligação a E-box com Dedos de Zinco / Glioma / Neovascularização Patológica Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Resistencia a Medicamentos Antineoplásicos / Efrina-B2 / Homeobox 2 de Ligação a E-box com Dedos de Zinco / Glioma / Neovascularização Patológica Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article